FindTrial
Sign In

A medical records based study for the prediction model construction of pathological complete response after neoadjuvant treatment of rectal cancer

Based on the characteristics of clinical data, the prediction model construction of pathological complete response after neoadjuvant treatment of rectal cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100046439
Enrollment
Unknown
Registered
2021-05-15
Start date
2021-05-16
Completion date
Unknown
Last updated
2022-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rectal cnacer

Interventions

case series:None

Sponsors

West China Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. The patient himself signs the informed consent form; 2. Provide contact information and be able to use the mobile phone to receive follow-up reminders and appointments.

Exclusion criteria

Exclusion criteria: 1. The patient's colorectal cancer tumor is non-primary, and is a metastatic tumor derived from other organs; 2. There is no TRG ending point.

Design outcomes

Primary

MeasureTime frame
tumor regression grade;—

Countries

China

Contacts

Public ContactWang Xiaodong

West China of Medicine, Sichuan University

lockwan@qq.com+86 13882267388

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026